Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 30, 2025
Inoperable POLE-mutated endometrial carcinoma: treatment beyond current guidelines
Bas L R Mandos, Sander Kelderman, Janneke E W Walraven, et al.
British Journal of Clinical Pharmacology
|
December 2, 2025
Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat
Annemieke M Peters van Ton, Nielka P van Erp, Annenienke C van de Ven, et al.
Cancer Immunology, Immunotherapy : CII
|
December 19, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer
Prashant Changoer, Chunying Peng, Pepijn van Houten, et al.
European Thyroid Journal
|
July 24, 2024
Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma
Pepijn van Houten, James Nagarajah, Janneke E W Walraven, et al.
European Thyroid Journal
|
June 8, 2026
Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study
Prashant Changoer, Pepijn van Houten, Daniele Ceruti, et al.
Journal of Clinical Medicine
|
May 25, 2024
Development and Internal Validation of Nomograms for Survival of Advanced Epithelial Ovarian Cancer Based on Established Prognostic Factors and Hematologic Parameters
Sherin Abdo Said, Joanna IntHout, Judith E den Ouden, et al.
BMC Health Services Research
|
June 27, 2022
Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review
Janneke E W Walraven, Olga L van der Hel, J J M van der Hoeven, et al.
BMC Medical Education
|
June 27, 2022
Preparing tomorrow's medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs
Janneke E W Walraven, Renske van der Meulen, Jacobus J M van der Hoeven, et al.
BMJ Open Quality
|
February 9, 2023
Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting
Janneke E W Walraven, Rob H A Verhoeven, Renske van der Meulen, et al.
Frontiers in Oncology
|
June 5, 2023
Pros and cons of streamlining and use of computerised clinical decision support systems to future-proof oncological multidisciplinary team meetings
Janneke E W Walraven, Rob H A Verhoeven, Jacobus J M van der Hoeven, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 30, 2025
Inoperable POLE-mutated endometrial carcinoma: treatment beyond current guidelines
Bas L R Mandos, Sander Kelderman, Janneke E W Walraven, et al.
British Journal of Clinical Pharmacology
|
December 2, 2025
Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat
Annemieke M Peters van Ton, Nielka P van Erp, Annenienke C van de Ven, et al.
Cancer Immunology, Immunotherapy : CII
|
December 19, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer
Prashant Changoer, Chunying Peng, Pepijn van Houten, et al.
European Thyroid Journal
|
July 24, 2024
Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma
Pepijn van Houten, James Nagarajah, Janneke E W Walraven, et al.
European Thyroid Journal
|
June 8, 2026
Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study
Prashant Changoer, Pepijn van Houten, Daniele Ceruti, et al.
Journal of Clinical Medicine
|
May 25, 2024
Development and Internal Validation of Nomograms for Survival of Advanced Epithelial Ovarian Cancer Based on Established Prognostic Factors and Hematologic Parameters
Sherin Abdo Said, Joanna IntHout, Judith E den Ouden, et al.
BMC Health Services Research
|
June 27, 2022
Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review
Janneke E W Walraven, Olga L van der Hel, J J M van der Hoeven, et al.
BMC Medical Education
|
June 27, 2022
Preparing tomorrow's medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs
Janneke E W Walraven, Renske van der Meulen, Jacobus J M van der Hoeven, et al.
BMJ Open Quality
|
February 9, 2023
Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting
Janneke E W Walraven, Rob H A Verhoeven, Renske van der Meulen, et al.
Frontiers in Oncology
|
June 5, 2023
Pros and cons of streamlining and use of computerised clinical decision support systems to future-proof oncological multidisciplinary team meetings
Janneke E W Walraven, Rob H A Verhoeven, Jacobus J M van der Hoeven, et al.
Page
of 2